The CLINICAL Discoloration Repair Serum contains 3% tranexamic acid, 5% niacinamide and 0.5% bakuchiol which is ideal for targeting stubborn discolouration and is even suitable for those with melasma-prone skin
A fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy
Strenuous exercise promotes a buildup of metabolites, leading to the formation of reactive oxygen species (ROS), which may contribute to additional muscle damage [13]
Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use
Pharmaceutical manufacturing processes, coupled with extensive consumption practices including improper disposal of unused or expired medications serve as primary sources of pharmaceutical residues, also known as emerging contaminants (ECs) [4]
